Nephrology Medical News about glomerulonephritis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF- activation
American Journal of Physiology: Renal Physiology, 09/03/09

Daniel C et al. – The data demonstrate TSP–2 as a potential therapeutic agent to inhibit the glomerular proliferative and inflammatory response as well as TGF–beta activation and extracellular matrix accumulation in experimental mesangial proliferative glomerulonephritis.

<< Previous
Rac1 promotes TGF-beta-stimulated mesangial cell type-I collagen...

Next >>
Multiperc Versus Single Perc with Flexible Instrumentation for...

Renal Progenitor Cells Contribute to Hyperplastic Lesions of Podocytopathies and Crescentic Glomerulonephritis
Journal of the American Society of Nephrology, 11/03/09 Relevance Score: 87%

Acute post-streptococcal glomerulonephritis in children of French Polynesia: a 3-year retrospective study
Pediatric Nephrology, 11/04/09 Relevance Score: 85%

The Spectrum of Adult Postinfectious Glomerulonephritis in the New Millennium
Renal Failure, 10/26/09 Relevance Score: 85%

Th1 and Th17 Cells Induce Proliferative Glomerulonephritis
Journal of the American Society of Nephrology, 10/12/09 Relevance Score: 85%

Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis
Nephrology, 10/05/09 Relevance Score: 85%